Proteostasis Therapeutics Obtains $10,000,000 New Funding

  • Feed Type
  • Date
    9/16/2015
  • Company Name
    Proteostasis Therapeutics
  • Mailing Address
    200 Technology Square 4th Floor Cambridge, MA 02139 USA
  • Company Description
    Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body’s Proteostasis Network, which maintains the body’s natural protein homeostasis to protect us from numerous diseases.
  • Website
    http://www.proteostasis.com
  • Transaction Type
    Debt
  • Transaction Amount
    $10,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing – amended. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities or debt.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy